Skip to content
CNS Clinical Research

Decatur, Georgia

CNS clinical trials in Decatur, GA

33 CNS studies are recruiting participants at sites in Decatur as of November 16, 2026, according to ClinicalTrials.gov. CNS Clinical Research can help you understand your options and connect with a study team.

Call (888) 520-7418
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Decatur at a glance

  • 33 studies are recruiting at a site in Decatur.
  • By phase: Phase 1 (3), Phase 2 (11), Phase 2/3 (1), Phase 3 (15), Phase 4 (2), No phase (1). Studies of devices and behavioral approaches have no phase.
  • By sponsor: industry (31), government (1), university, hospital or other (1).
  • By research area: Depression (12), Schizophrenia (11), Migraine (3), Parkinson's Disease (3), ADHD (2), Bipolar Disorder (2).
  • Most recent update to one of these records: November 16, 2026.

Depression studies recruiting in Decatur

Basic details from each study's public record (the 30 most recently updated of 33). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Double-blind, Placebo-controlled Study in Adults With Major Depressive Disorder

    • Phase 2
    • Ages 18 to 70
    • All sexes
    Sponsor
    Supernus Pharmaceuticals, Inc.
    Study site
    Cenexel iResearch Atlanta
    Registry record
    NCT07226661 · updated
  2. A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)

    • Phase 2
    • Ages 18 to 65
    • All sexes
    Sponsor
    Seaport Therapeutics
    Study site
    Seaport Investigator Site
    Registry record
    NCT07065240 · updated
  3. A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)

    • Phase 3
    • Ages 18 to 74
    • All sexes
    Sponsor
    Definium Therapeutics US, Inc.
    Study site
    CenExel - iResearch Atlanta
    Registry record
    NCT07592689 · updated
  4. E-Mindfulness Approaches for Living After Breast Cancer

    • Phase 3
    • Ages 18 to 50
    • All sexes
    Sponsor
    NRG Oncology
    Study site
    Emory Decatur Hospital
    Registry record
    NCT06748222 · updated
  5. A Study of Brenipatide in Adult Participants With Major Depressive Disorder

    • Phase 3
    • Ages 18 to 75
    • All sexes
    Sponsor
    Eli Lilly and Company
    Study site
    CenExel iResearch, LLC
    Registry record
    NCT07412756 · updated
  6. Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder

    • Phase 3
    • Ages 18 to 65
    • All sexes
    Sponsor
    Intra-Cellular Therapies, Inc.
    Study site
    CenExeli Research LLC
    Registry record
    NCT05850689 · updated
  7. A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression

    • Phase 2
    • Ages 18 to 75
    • All sexes
    Sponsor
    Draig Therapeutics Ltd
    Study site
    Draig Clinical Site
    Registry record
    NCT07610473 · updated
  8. A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression

    • Phase 2
    • Ages 18 to 75
    • All sexes
    Sponsor
    Draig Therapeutics Ltd
    Study site
    Draig Clinical Site
    Registry record
    NCT07300969 · updated
  9. Brexanolone Lifting Outcomes Of Moms

    • Phase 3
    • Ages 15 to 45
    • Female participants
    Sponsor
    Lipocine Inc.
    Study site
    Lipocine Investigational Site
    Registry record
    NCT07822321 · updated
  10. A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.

    • Phase 3
    • Ages 10 to 17
    • All sexes
    Sponsor
    AbbVie
    Study site
    CenExcel iResearch LLC /ID# 228695
    Registry record
    NCT04777357 · updated
  11. Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With BP1MDE.

    • Phase 2
    • Ages 18 to 65
    • All sexes
    Sponsor
    LB Pharmaceuticals Inc.
    Study site
    Cenexel Decatur GA
    Registry record
    NCT07494305 · updated

Source: ClinicalTrials.gov. Data processed . See every depression study recruiting in Decatur, GA on ClinicalTrials.gov.

Schizophrenia studies recruiting in Decatur

  1. Study to Evaluate Efficacy and Safety of Roluperidone in Adult Subjects With Negative Symptoms and Stable Positive Symptoms of Schizophrenia and to Evaluate the Relapse Rate of Roluperidone and Antipsychotic Medications

    • Phase 3
    • Ages 18 to 55
    • All sexes
    Sponsor
    Minerva Neurosciences
    Study site
    CenExel iResearch, LLC
    Registry record
    NCT07565428 · updated
  2. A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia

    • Phase 2
    • Ages 18 to 65
    • All sexes
    Sponsor
    MapLight Therapeutics
    Registry record
    NCT07459647 · updated
  3. Safety and Tolerability of Open-Labeled Iloperidone in Adolescents

    • Phase 4
    • Ages 12 to 17
    • All sexes
    Sponsor
    Vanda Pharmaceuticals
    Study site
    Vanda Investigational Site
    Registry record
    NCT05648591 · updated
  4. NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia

    • Phase 3
    • Ages 18 to 65
    • All sexes
    Sponsor
    Neurocrine Biosciences
    Study site
    Neurocrine Clinical Site
    Registry record
    NCT07114874 · updated
  5. A Study of LTX-001 In Adult Participants With Acute Exacerbation of Schizophrenia

    • Phase 1
    • Ages 18 to 55
    • All sexes
    Sponsor
    Leal Therapeutics, Inc
    Study site
    CenExel iResearch, LLC
    Registry record
    NCT07734493 · updated
  6. A Study to Evaluate the Safety, Tolerability, and PK of an Injectable Form of KarXT

    • Phase 1
    • Ages 18 to 55
    • All sexes
    Sponsor
    Bristol-Myers Squibb
    Study site
    CenExel iResearch, LLC
    Registry record
    NCT07061288 · updated
  7. Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder

    • Phase 3
    • Ages 10 to 17
    • All sexes
    Sponsor
    Alkermes, Inc.
    Study site
    Alkermes Investigator Site
    Registry record
    NCT05303064 · updated
  8. Determining Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar Disorder

    • Phase 1
    • Ages 10 to 17
    • All sexes
    Sponsor
    BioXcel Therapeutics Inc
    Study site
    Bioxcel Clinical Research Site
    Registry record
    NCT05025605 · updated
  9. Study to Assess the Safety, Tolerability, and Treatment Response of GXV813 in Hospitalized Adults With Schizophrenia

    • Phase 2
    • Ages 18 to 65
    • All sexes
    Sponsor
    Novartis Pharmaceuticals
    Study site
    CenExel iResearch
    Registry record
    NCT07467993 · updated

Source: ClinicalTrials.gov. Data processed . See every schizophrenia study recruiting in Decatur, GA on ClinicalTrials.gov.

Bipolar disorder studies recruiting in Decatur

  1. A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-2)

    • Phase 3
    • Ages 18 to 65
    • All sexes
    Sponsor
    Bristol-Myers Squibb
    Study site
    CenExel iResearch, LLC
    Registry record
    NCT06951711 · updated
  2. A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)

    • Phase 3
    • Ages 18 to 65
    • All sexes
    Sponsor
    Bristol-Myers Squibb
    Study site
    CenExel iResearch, LLC
    Registry record
    NCT06929273 · updated

Source: ClinicalTrials.gov. Data processed . See every bipolar disorder study recruiting in Decatur, GA on ClinicalTrials.gov.

ADHD studies recruiting in Decatur

  1. A Study to Evaluate Safety and Efficacy of ALKS 7290 Compared With Placebo in Adult Participants With Attention Deficit Hyperactivity Disorder (ALKS 7290-201)

    • Phase 2
    • Ages 18 to 65
    • All sexes
    Sponsor
    Alkermes, Inc.
    Study site
    Alkermes Investigational Site
    Registry record
    NCT07755410 · updated
  2. Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD

    • Phase 4
    • From 48 months, up to 69 months
    • All sexes
    Sponsor
    Supernus Pharmaceuticals, Inc.
    Study site
    CenExcel iResearch, LLC
    Registry record
    NCT04781140 · updated

Source: ClinicalTrials.gov. Data processed . See every ADHD study recruiting in Decatur, GA on ClinicalTrials.gov.

Parkinson's disease studies recruiting in Decatur

  1. A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy

    • Phase 2
    • Ages 18 to 65
    • All sexes
    Sponsor
    Vima Therapeutics
    Study site
    Vima Site #045
    Registry record
    NCT07804615 · updated
  2. A Study of Buntanetap in Participants With PD

    • Phase 2/3
    • Ages 40 to 85
    • All sexes
    Sponsor
    Annovis Bio Inc.
    Study site
    iResearch Atlanta
    Registry record
    NCT07284784 · updated
  3. Moderate Versus High Volume Light-Moderate Intensity Exercise for People With Moderate Parkinson's Disease

    • No phase
    • Ages 40 and older
    • All sexes
    Sponsor
    VA Office of Research and Development
    Study site
    Atlanta VA Medical and Rehab Center, Decatur, GA
    Registry record
    NCT06088355 · updated

Source: ClinicalTrials.gov. Data processed . See every Parkinson's disease study recruiting in Decatur, GA on ClinicalTrials.gov.

Migraine studies recruiting in Decatur

  1. Study of EVO756 in Adults With Migraine

    • Phase 2
    • Ages 18 to 64
    • All sexes
    Sponsor
    Evommune, Inc.
    Study site
    Accel Research Site-Decatur-Alcanza
    Registry record
    NCT07616128 · updated
  2. Randomized Study in Children and Adolescents With Migraine: Acute Treatment

    • Phase 3
    • Ages 6 to 17
    • All sexes
    Sponsor
    Pfizer
    Study site
    CenExel iResearch, LLC
    Registry record
    NCT04649242 · updated
  3. Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine

    • Phase 3
    • Ages 6 to 17
    • All sexes
    Sponsor
    Pfizer
    Study site
    CenExel iResearch, LLC
    Registry record
    NCT04743141 · updated

Source: ClinicalTrials.gov. Data processed . See every migraine study recruiting in Decatur, GA on ClinicalTrials.gov.

Ask about studies near Decatur

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

More locations in Georgia

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.

CNS Clinical Research does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 520-7418

or send a short form

How should we reach you?

Call